Genetic variability of HIF1A and response to treatment with cisplatin in combination with pemetrexed or gemcitabine in patients with malignant mesothelioma
, , , , e
05 set 2025
INFORMAZIONI SU QUESTO ARTICOLO
Pubblicato online: 05 set 2025
Pagine: 403 - 411
Ricevuto: 15 giu 2025
Accettato: 19 lug 2025
DOI: https://doi.org/10.2478/raon-2025-0049
Parole chiave
© 2025 Matic Setina et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Setina, Matic
Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Setina, Eva
Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Doljak, Ziga
Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Goricar, Katja
Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Dolzan, Vita
Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Kovac, Viljem
Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Institute of Oncology LjubljanaLjubljana, Slovenia